{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T04:10:57Z","timestamp":1791691857727,"version":"4.3.4"},"reference-count":147,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Project \u201cHEAL ITALIA-Health Extended Alliance for Innovative Therapies, Advanced Lab-research, and Integrated Approaches of Precision Medicine-Cod","award":["PE_00000019"],"award-info":[{"award-number":["PE_00000019"]}]},{"name":"Project \u201cHEAL ITALIA-Health Extended Alliance for Innovative Therapies, Advanced Lab-research, and Integrated Approaches of Precision Medicine-Cod","award":["341\/2022"],"award-info":[{"award-number":["341\/2022"]}]},{"name":"European Union \u201cNextGenerationUE","award":["PE_00000019"],"award-info":[{"award-number":["PE_00000019"]}]},{"name":"European Union \u201cNextGenerationUE","award":["341\/2022"],"award-info":[{"award-number":["341\/2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD), the most common neurodegenerative disease (NDD), is characterized by chronic neuronal cell death through progressive loss of cognitive function. Amyloid beta (A\u03b2) deposition, neuroinflammation, oxidative stress, and hyperphosphorylated tau proteins are considered the hallmarks of AD pathology. Different therapeutic approaches approved by the Food and Drug Administration can only target a single altered pathway instead of various mechanisms that are involved in AD pathology, resulting in limited symptomatic relief and almost no effect in slowing down the disease progression. Growing evidence on modulating the components of the endocannabinoid system (ECS) proclaimed their neuroprotective effects by reducing neurochemical alterations and preventing cellular dysfunction. Recent studies on AD mouse models have reported that the inhibitors of the fatty acid amide hydrolase (FAAH) and monoacylglycerol (MAGL), hydrolytic enzymes for N-arachidonoyl ethanolamine (AEA) and 2-arachidonoylglycerol (2-AG), respectively, might be promising candidates as therapeutical intervention. The FAAH and MAGL inhibitors alone or in combination seem to produce neuroprotection by reversing cognitive deficits along with A\u03b2-induced neuroinflammation, oxidative responses, and neuronal death, delaying AD progression. Their exact signaling mechanisms need to be elucidated for understanding the brain intrinsic repair mechanism. The aim of this review was to shed light on physiology and pathophysiology of AD and to summarize the experimental data on neuroprotective roles of FAAH and MAGL inhibitors. In this review, we have also included CB1R and CB2R modulators with their diverse roles to modulate ECS mediated responses such as anti-nociceptive, anxiolytic, and anti-inflammatory actions in AD. Future research would provide the directions in understanding the molecular mechanisms and development of new therapeutic interventions for the treatment of AD.<\/jats:p>","DOI":"10.3390\/ijms25074050","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T08:27:52Z","timestamp":1712305672000},"page":"4050","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6281-562X","authenticated-orcid":false,"given":"Hina","family":"Kanwal","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-8843","authenticated-orcid":false,"given":"Moris","family":"Sangineto","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Ciarnelli","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0530-2262","authenticated-orcid":false,"given":"Pasqualina","family":"Castaldo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Public Health, School of Medicine, University \u201cPolitecnica delle Marche\u201d, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9875-019X","authenticated-orcid":false,"given":"Rosanna","family":"Villani","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0559-2917","authenticated-orcid":false,"given":"Antonino","family":"Romano","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6424-7841","authenticated-orcid":false,"given":"Gaetano","family":"Serviddio","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-806X","authenticated-orcid":false,"given":"Tommaso","family":"Cassano","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00702-013-1129-3","article-title":"Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle","volume":"122","author":"Buga","year":"2015","journal-title":"J. Neural Transm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jnc.14148","article-title":"Epigenetics and DNA methylomic profiling in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"143","author":"Roubroeks","year":"2017","journal-title":"J. Neurochem."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Di Benedetto, G., Burgaletto, C., Bellanca, C.M., Munaf\u00f2, A., Bernardini, R., and Cantarella, G. (2022). Role of Microglia and Astrocytes in Alzheimer\u2019s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation. Cells, 11.","DOI":"10.3390\/cells11172728"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2003054","DOI":"10.1002\/adfm.202003054","article-title":"Recent advancements of nanomedicine in neurodegenerative disorders theranostics","volume":"30","author":"Mukherjee","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gallelli, C.A., Calcagnini, S., Romano, A., Koczwara, J.B., De Ceglia, M., Dante, D., Villani, R., Giudetti, A.M., Cassano, T., and Gaetani, S. (2018). Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues. Antioxidants, 7.","DOI":"10.3390\/antiox7070093"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3233\/JAD-141635","article-title":"The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer\u2019s disease","volume":"43","author":"Bedse","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1098\/rstb.2012.0313","article-title":"Endocannabinoids in nervous system health and disease: The big picture in a nutshell","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-21737-2_1","article-title":"Endocannabinoid system components: Overview and tissue distribution","volume":"1162","author":"Joshi","year":"2019","journal-title":"Recent Adv. Cannabinoid Physiol. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/febs.12212","article-title":"Transport of endocannabinoids across the plasma membrane and within the cell","volume":"280","author":"Fowler","year":"2013","journal-title":"FEBS J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e13370","DOI":"10.1111\/nmo.13370","article-title":"Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans","volume":"30","author":"Camilleri","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Simard, M., Archambault, A.-S., Lavoie, J.-P.C., Dumais, \u00c9., Di Marzo, V., and Flamand, N. (2022). Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families. Biochem. Pharmacol., 205.","DOI":"10.1016\/j.bcp.2022.115261"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2018.05.002","article-title":"2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain","volume":"71","author":"Baggelaar","year":"2018","journal-title":"Prog. Lipid Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105237","DOI":"10.1016\/j.phrs.2020.105237","article-title":"Epigenetics and the endocannabinoid system signaling: An intricate interplay modulating neurodevelopment","volume":"162","author":"Gomes","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/bph.12411","article-title":"Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS","volume":"171","author":"Murataeva","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/imm.12441","article-title":"Endocannabinoid signalling in innate and adaptive immunity","volume":"144","author":"Battistini","year":"2015","journal-title":"Immunology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/bs.vh.2014.12.011","article-title":"Endocannabinoid transport revisited","volume":"98","author":"Nicolussi","year":"2015","journal-title":"Vitam. Horm."},{"key":"ref_18","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102196","DOI":"10.1016\/j.npep.2021.102196","article-title":"Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer\u2019s disease","volume":"90","author":"Rapaka","year":"2021","journal-title":"Neuropeptides"},{"key":"ref_20","first-page":"9565545","article-title":"Molecular Signatures of Mitochondrial Complexes Involved in Alzheimer\u2019s Disease via Oxidative Phosphorylation and Retrograde Endocannabinoid Signaling Pathways","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-319-20825-1_8","article-title":"Endocannabinoids and neurodegenerative disorders: Parkinson\u2019s disease, Huntington\u2019s chorea, Alzheimer\u2019s disease, and others","volume":"231","author":"Romero","year":"2015","journal-title":"Endocannabinoids"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/joim.12959","article-title":"Current and emerging avenues for Alzheimer\u2019s disease drug targets","volume":"286","author":"Kenigsberg","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2174\/0929867322666150114151720","article-title":"Catalpol: A potential therapeutic for neurodegenerative diseases","volume":"22","author":"Jiang","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/jnr.24718","article-title":"Locus Coeruleus and neurovascular unit: From its role in physiology to its potential role in Alzheimer\u2019s disease pathogenesis","volume":"98","author":"Giorgi","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","article-title":"Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson\u2019s disease and Alzheimer\u2019s disease","volume":"147","author":"Jiang","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/164_2019_298","article-title":"Molecular mechanism and cannabinoid pharmacology","volume":"258","author":"Schurman","year":"2020","journal-title":"Subst. Use Disord. Etiol. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bbamem.2011.08.034","article-title":"The role of the lipid matrix for structure and function of the GPCR rhodopsin","volume":"1818","author":"Soubias","year":"2012","journal-title":"Biochim. Et Biophys. Acta (BBA)-Biomembr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/0024-3205(95)00178-9","article-title":"Construction of a 3d model of the cannabinoid cb1 receptor: Determination of hellx ends and hellx orientation","volume":"56","author":"RD","year":"1995","journal-title":"Life Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bies.201500046","article-title":"Dissecting the cannabinergic control of behavior: The where matters","volume":"37","author":"Desprez","year":"2015","journal-title":"BioEssays"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-030-21737-2_6","article-title":"Endocannabinoid system and alcohol abuse disorders","volume":"1162","author":"Basavarajappa","year":"2019","journal-title":"Recent Adv. Cannabinoid Physiol. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.neuron.2018.08.014","article-title":"Hippocampal CB1 receptors control incidental associations","volume":"99","author":"Terral","year":"2018","journal-title":"Neuron"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/npp.2015.280","article-title":"Enhanced glutamatergic synaptic plasticity in the hippocampal CA1 field of food-restricted rats: Involvement of CB1 receptors","volume":"41","author":"Talani","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jnc.14098","article-title":"Endocannabinoid system in neurodegenerative disorders","volume":"142","author":"Basavarajappa","year":"2017","journal-title":"J. Neurochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3389\/fphar.2019.00644","article-title":"Astrocyte function is affected by aging and not Alzheimer\u2019s disease: A preliminary investigation in hippocampi of 3xTg-AD mice","volume":"10","author":"Bronzuoli","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuint.2011.11.004","article-title":"[125I] SD-7015 reveals fine modalities of CB1 cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer\u2019s disease","volume":"60","author":"Farkas","year":"2012","journal-title":"Neurochem. Int."},{"key":"ref_36","first-page":"1038","article-title":"Functional autoradiography shows unaltered cannabinoid CB1 receptor signalling in hippocampus and cortex of APP\/PS1 transgenic mice","volume":"11","author":"Karkkainen","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets (Former. Curr. Drug Targets-CNS Neurol. Disord.)"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.euroneuro.2013.10.002","article-title":"In vivo type 1 cannabinoid receptor availability in Alzheimer\u2019s disease","volume":"24","author":"Ahmad","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3233\/JAD-131910","article-title":"Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer\u2019s disease","volume":"40","author":"Bedse","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","article-title":"Cannabinoids in neurodegenerative disorders and stroke\/brain trauma: From preclinical models to clinical applications","volume":"12","author":"Moro","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kibret, B.G., Ishiguro, H., Horiuchi, Y., and Onaivi, E.S. (2022). New insights and potential therapeutic targeting of CB2 cannabinoid receptors in CNS disorders. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020975"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Azam, S., Haque, M.E., Jakaria, M., Jo, S.-H., Kim, I.-S., and Choi, D.-K. (2020). G-protein-coupled receptors in CNS: A potential therapeutic target for intervention in neurodegenerative disorders and associated cognitive deficits. Cells, 9.","DOI":"10.3390\/cells9020506"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejim.2018.01.009","article-title":"The therapeutic potential of targeting the peripheral endocannabinoid\/CB1 receptor system","volume":"49","author":"Tam","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1007\/s12035-020-02054-6","article-title":"Current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson\u2019s and Alzheimer\u2019s diseases: A review","volume":"57","author":"Cooray","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e72560","DOI":"10.7554\/eLife.72560","article-title":"Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams\u2013Beuren syndrome","volume":"11","author":"Pastor","year":"2022","journal-title":"Elife"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4720532","DOI":"10.1155\/2018\/4720532","article-title":"Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer\u2019s disease: In vitro and in vivo evidence","volume":"2018","author":"Bronzuoli","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e61339","DOI":"10.7554\/eLife.61339","article-title":"Magnesium efflux from Drosophila Kenyon cells is critical for normal and diet-enhanced long-term memory","volume":"9","author":"Wu","year":"2020","journal-title":"Elife"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3389\/fphar.2020.01097","article-title":"Emerging promise of cannabinoids for the management of pain and associated neuropathological alterations in Alzheimer\u2019s disease","volume":"11","author":"Uddin","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","article-title":"Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus","volume":"90","author":"Stempel","year":"2016","journal-title":"Neuron"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.febslet.2015.05.007","article-title":"Regulation of neuronal communication by G protein-coupled receptors","volume":"589","author":"Huang","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_51","unstructured":"Kotzadimitriou, D. (2016). Altered Function of CCK-Positive Interneurons in Mice Over-Expressing the Schizophrenia Risk Gene Neuregulin 1, University of Oxford."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bbadis.2015.11.011","article-title":"Imaging of neuroinflammation in Alzheimer\u2019s disease, multiple sclerosis and stroke: Recent developments in positron emission tomography","volume":"1862","author":"Janssen","year":"2016","journal-title":"Biochim. Et Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fnins.2016.00243","article-title":"CB2 cannabinoid receptor as potential target against Alzheimer\u2019s disease","volume":"10","author":"Aso","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Komorowska-M\u00fcller, J.A., and Schm\u00f6le, A.-C. (2020). CB2 receptor in microglia: The guardian of self-control. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010019"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_56","first-page":"771442","article-title":"Stefano Pallanti 1, 2*, Anna Marras 1, 3 and Nikolaos Makris 4. The Endocannabinoid System: Filling the Translational Gap between Neuroscience and Psychiatry","volume":"12","author":"Colizzi","year":"2022","journal-title":"Front. Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuint.2019.02.008","article-title":"Forsythiaside prevents \u03b2-amyloid-induced hippocampal slice injury by upregulating 2-arachidonoylglycerol via cannabinoid receptor 1-dependent NF-\u03baB pathway","volume":"125","author":"Chen","year":"2019","journal-title":"Neurochem. Int."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Xiong, Y., and Lim, C.-S. (2021). Understanding the modulatory effects of cannabidiol on Alzheimer\u2019s disease. Brain Sci., 11.","DOI":"10.3390\/brainsci11091211"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fphar.2014.00037","article-title":"Cannabinoids for treatment of Alzheimer\u2019s disease: Moving toward the clinic","volume":"5","author":"Aso","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ledesma, J.C., Rodr\u00edguez-Arias, M., Gavito, A.L., S\u00e1nchez-P\u00e9rez, A.M., Vi\u00f1a, J., Medina Vera, D., Rodr\u00edguez de Fonseca, F., and Mi\u00f1arro, J. (2021). Adolescent binge-ethanol accelerates cognitive impairment and \u03b2-amyloid production and dysregulates endocannabinoid signaling in the hippocampus of APP\/PSE mice. Addict. Biol., 26.","DOI":"10.1111\/adb.12883"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1755-5949.2010.00195.x","article-title":"The multiplicity of action of cannabinoids: Implications for treating neurodegeneration","volume":"17","author":"Gowran","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.3233\/JAD-201074","article-title":"Hypoxia, oxidative stress, and inflammation: Three faces of neurodegenerative diseases","volume":"82","author":"Merelli","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1523\/JNEUROSCI.21-01-00109.2001","article-title":"Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens","volume":"21","author":"Robbe","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/01616412.2021.2004364","article-title":"Electrophysiological study of the interactive role of the cannabinoid breakdown inhibitors and L-type calcium channels on granular neurons in the hippocampal dentate gyrus in rats","volume":"44","author":"Karimi","year":"2022","journal-title":"Neurol. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cbf.3680","article-title":"The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer\u2019s disease","volume":"40","author":"Jain","year":"2022","journal-title":"Cell Biochem. Funct."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000338494","article-title":"CB1 cannabinoid receptor activation rescues amyloid \u03b2-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones","volume":"29","author":"Haghani","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41401-020-0385-7","article-title":"Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases\u2014Focusing on FAAH\/MAGL inhibitors","volume":"41","author":"Ren","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.brainresbull.2021.06.022","article-title":"The role of endocannabinoid pathway in the neuropathology of Alzheimer\u2019s disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer\u2019s disease?","volume":"174","author":"Bajaj","year":"2021","journal-title":"Brain Res. Bull."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Papa, A., Pasquini, S., Contri, C., Gemma, S., Campiani, G., Butini, S., Varani, K., and Vincenzi, F. (2022). Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition. Cells, 11.","DOI":"10.3390\/cells11030471"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-20825-1_3","article-title":"Distribution of the endocannabinoid system in the central nervous system","volume":"231","author":"Hu","year":"2015","journal-title":"Endocannabinoids"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2015.10.001","article-title":"The endocannabinoid signaling system in the CNS: A primer","volume":"125","author":"Hillard","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/acs.jmedchem.6b00538","article-title":"Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and N-acylethanolamine acid amidase inhibitors","volume":"60","author":"Tuo","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Lowe, H., Toyang, N., Steele, B., Bryant, J., and Ngwa, W. (2021). The endocannabinoid system: A potential target for the treatment of various diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179472"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-008-9075-y","article-title":"Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation","volume":"11","author":"Schlosburg","year":"2009","journal-title":"AAPS J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.advms.2018.06.002","article-title":"Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism","volume":"64","author":"Biernacki","year":"2019","journal-title":"Adv. Med. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/bph.13337","article-title":"Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine neuropathic pain model","volume":"173","author":"Mitchell","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1124\/jpet.115.222851","article-title":"Full fatty acid amide hydrolase inhibition combined with partial monoacylglycerol lipase inhibition: Augmented and sustained antinociceptive effects with reduced cannabimimetic side effects in mice","volume":"354","author":"Ghosh","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuint.2017.08.003","article-title":"Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson\u2019s disease","volume":"110","author":"Pasquarelli","year":"2017","journal-title":"Neurochem. Int."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Rusek, M., Pluta, R., U\u0142amek-Kozio\u0142, M., and Czuczwar, S.J. (2019). Ketogenic diet in Alzheimer\u2019s disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163892"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00702-014-1293-0","article-title":"Common mechanisms in neurodegeneration and neuroinflammation: A BrainNet Europe gene expression microarray study","volume":"122","author":"Durrenberger","year":"2015","journal-title":"J. Neural Transm."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12640-016-9626-4","article-title":"Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson\u2019s and Alzheimer\u2019s Disease Patients","volume":"30","author":"Montarolo","year":"2016","journal-title":"Neurotox. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s41048-019-0086-2","article-title":"Identification of key genes and pathways for Alzheimer\u2019s disease via combined analysis of genome-wide expression profiling in the hippocampus","volume":"5","author":"Wu","year":"2019","journal-title":"Biophys. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"135208","DOI":"10.1016\/j.neulet.2020.135208","article-title":"Increased GABAergic development in iPSC-derived neurons from patients with sporadic Alzheimer\u2019s disease","volume":"735","author":"Tang","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Abyadeh, M., Tofigh, N., Hosseinian, S., Hasan, M., Amirkhani, A., Fitzhenry, M.J., Gupta, V., Chitranshi, N., Salekdeh, G.H., and Haynes, P.A. (2022). Key genes and biochemical networks in various brain regions affected in Alzheimer\u2019s disease. Cells, 11.","DOI":"10.3390\/cells11060987"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12640-016-9632-6","article-title":"Transient Receptor Potential Channels in Microglia: Roles in Physiology and Disease","volume":"30","author":"Echeverry","year":"2016","journal-title":"Neurotox. Res."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Yang, S., Du, Y., Zhao, X., Tang, Q., Su, W., Hu, Y., and Yu, P. (2022). Cannabidiol enhances microglial Beta-amyloid peptide phagocytosis and clearance via Vanilloid family type 2 channel activation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105367"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/bph.12615","article-title":"Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation","volume":"171","author":"Hassan","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41401-022-01000-7","article-title":"Activation of TRPV1 receptor facilitates myelin repair following demyelination via the regulation of microglial function","volume":"44","author":"Sun","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/brain.2020.0879","article-title":"Understanding changes in hippocampal interneurons subtypes in the pathogenesis of Alzheimer\u2019s disease: A systematic review","volume":"11","author":"Reid","year":"2021","journal-title":"Brain Connect."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fneur.2020.00087","article-title":"Endocannabinoid modulation of microglial phenotypes in neuropathology","volume":"11","author":"Tanaka","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Leo, L.M., and Abood, M.E. (2021). CB1 cannabinoid receptor signaling and biased signaling. Molecules, 26.","DOI":"10.3390\/molecules26175413"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Hryhorowicz, S., Kaczmarek-Ry\u015b, M., Andrzejewska, A., Staszak, K., Hryhorowicz, M., Korcz, A., and S\u0142omski, R. (2019). Allosteric modulation of cannabinoid receptor 1\u2014Current challenges and future opportunities. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235874"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/med.21418","article-title":"Allosteric modulation: An alternate approach targeting the cannabinoid CB1 receptor","volume":"37","author":"Nguyen","year":"2017","journal-title":"Med. Res. Rev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/acschemneuro.6b00310","article-title":"Enantiospecific allosteric modulation of cannabinoid 1 receptor","volume":"8","author":"Laprairie","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Polini, B., Cervetto, C., Carpi, S., Pelassa, S., Gado, F., Ferrisi, R., Bertini, S., Nieri, P., Marcoli, M., and Manera, C. (2020). Positive allosteric modulation of CB1 and CB2 cannabinoid receptors enhances the neuroprotective activity of a dual CB1R\/CB2R orthosteric agonist. Life, 10.","DOI":"10.3390\/life10120333"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Abate, G., Uberti, D., and Tambaro, S. (2021). Potential and limits of cannabinoids in alzheimer\u2019s disease therapy. Biology, 10.","DOI":"10.3390\/biology10060542"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.drudis.2019.05.023","article-title":"Cannabinoid receptors as therapeutic targets for autoimmune diseases: Where do we stand?","volume":"24","author":"Dutra","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fphar.2020.00124","article-title":"From Cannabis sativa to cannabidiol: Promising therapeutic candidate for the treatment of neurodegenerative diseases","volume":"11","author":"Cassano","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"105729","DOI":"10.1016\/j.phrs.2021.105729","article-title":"The endocannabinoidome in neuropsychiatry: Opportunities and potential risks","volume":"170","author":"Morris","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"108555","DOI":"10.1016\/j.neuropharm.2021.108555","article-title":"The cannabinoid system and microglia in health and disease","volume":"190","author":"Duffy","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnins.2017.00030","article-title":"Cannabinoid receptor 2 signaling in neurodegenerative disorders: From pathogenesis to a promising therapeutic target","volume":"11","author":"Cassano","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/aps.2016.149","article-title":"Brain cannabinoid receptor 2: Expression, function and modulation","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41401-019-0210-3","article-title":"Cannabis, cannabinoid receptors, and endocannabinoid system: Yesterday, today, and tomorrow","volume":"40","author":"Wu","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Abd El-Rahman, S.S., and Fayed, H.M. (2022). Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB\/BDNF expression and impeding TLR-4\/NF\u03baBp65\/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0265961"},{"key":"ref_106","unstructured":"Elsouri, K. Amyloid Cascade Hypothesis Perspective on Alzheimer\u2019s Disease. [Ph.D. Thesis, Florida Atlantic University]."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Saras\u00faa, S., Fern\u00e1ndez-P\u00e9rez, I., Espinosa-Fern\u00e1ndez, V., S\u00e1nchez-P\u00e9rez, A.M., and Ledesma, J.C. (2020). Can we treat neuroinflammation in Alzheimer\u2019s disease?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228751"},{"key":"ref_108","first-page":"20","article-title":"The Neuroprotective Properties, Functions, and Roles of Cannabis sativa in Selected Diseases Related to the Nervous System","volume":"21","author":"Mahdi","year":"2021","journal-title":"Cent. Nerv. Syst. Agents Med. Chem. (Former. Curr. Med. Chem. Cent. Nerv. Syst. Agents)"},{"key":"ref_109","first-page":"1247","article-title":"Fatty acid amide hydrolase inhibitors: A patent review (2009\u20132014)","volume":"25","author":"Lodola","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/jcmm.13034","article-title":"Macrophage polarization: A key event in the secondary phase of acute spinal cord injury","volume":"21","author":"Kong","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2016.12.034","article-title":"URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy","volume":"344","author":"Wang","year":"2017","journal-title":"Neuroscience"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2174\/1570159X13666150612225212","article-title":"Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase: New targets for future antidepressants","volume":"13","author":"Ogawa","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/jpet.107.120147","article-title":"Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage","volume":"322","author":"Karanian","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/mp.2012.72","article-title":"Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity","volume":"18","author":"MacPherson","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1476-5381.2011.01445.x","article-title":"The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice","volume":"165","author":"Booker","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Battista, N., and Maccarrone, M. (2017). The Endocannabinoid System, Elsevier.","DOI":"10.1002\/9780470015902.a0027093"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejmech.2013.02.005","article-title":"Biaryl tetrazolyl ureas as inhibitors of endocannabinoid metabolism: Modulation at the N-portion and distal phenyl ring","volume":"63","author":"Ortar","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jneumeth.2011.11.028","article-title":"Impaired hippocampal glucoregulation in the cannabinoid CB1 receptor knockout mice as revealed by an optimized in vitro experimental approach","volume":"204","author":"Lemos","year":"2012","journal-title":"J. Neurosci. Methods"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cbpa.2009.04.616","article-title":"Endocannabinoid chemical biology: A tool for the development of novel therapies","volume":"13","author":"Petrosino","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1460-9568.2003.02470.x","article-title":"Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test","volume":"17","author":"Ates","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1111\/bph.12750","article-title":"The tyrosine kinase inhibitor bafetinib inhibits PAR 2-induced activation of TRPV 4 channels in vitro and pain in vivo","volume":"171","author":"Grace","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/cmdc.200900137","article-title":"Screening of various hormone-sensitive lipase inhibitors as endocannabinoid-hydrolyzing enzyme inhibitors","volume":"4","author":"Savinainen","year":"2009","journal-title":"ChemMedChem"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuropharm.2017.06.032","article-title":"Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice","volume":"125","author":"Owens","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acschemneuro.5b00248","article-title":"Synthesis and preliminary PET imaging studies of a FAAH radiotracer ([11C] MPPO) based on \u03b1-ketoheterocyclic scaffold","volume":"7","author":"Wang","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/157488912798842223","article-title":"Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid\u2019s activity by preventing their hydrolysis","volume":"7","author":"Feledziak","year":"2012","journal-title":"Recent Pat. CNS Drug Discov. (Discontin.)"},{"key":"ref_127","unstructured":"Myllym\u00e4ki, M. (2009). Synthesis of 3-heterocycle phenyl N-alkyl Carbamates and Their Activity as FAAH Inhibitors. [Ph.D. Thesis, Helsinki University of Technology, Department of Chemistry]."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1574889810999160603185126","article-title":"Beyond the direct activation of cannabinoid receptors: New strategies to modulate the endocannabinoid system in CNS-related diseases","volume":"10","author":"Chicca","year":"2015","journal-title":"Recent Pat. CNS Drug Discov. (Discontin.)"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2016.12.115","article-title":"Computational proteome-wide screening predicts neurotoxic drug-protein interactome for the investigational analgesic BIA 10\u20132474","volume":"483","author":"Molinski","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1021\/jm400923s","article-title":"Chiral 1, 3, 4-oxadiazol-2-ones as highly selective FAAH inhibitors","volume":"56","author":"Patel","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_131","unstructured":"Patel, J.Z. (2015). The development of potent and selective inhibitors of enzymes involved in endocannabinoid inactivation. [Ph.D. Thesis, University of Eastern Finland]."},{"key":"ref_132","unstructured":"Pertwee, R.G. (2020). Cannabinoid Receptor Ligands, University of Aberdeen."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1021\/acsmedchemlett.5b00353","article-title":"Preclinical characterization of the FAAH inhibitor JNJ-42165279","volume":"6","author":"Keith","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/01926233211010444","article-title":"Exacerbation of Background Nuclear Cataracts in Sprague-Dawley Rats in Embryo-Fetal Development Studies With JNJ-42165279, a Fatty Acid Amide Hydrolase Inhibitor","volume":"49","author":"Roosen","year":"2021","journal-title":"Toxicol. Pathol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1021\/jm701631z","article-title":"Synthesis and QSAR of fatty acid amide hydrolase inhibitors: Modulation at the N-portion of biphenyl-3-yl alkylcarbamates","volume":"51","author":"Mor","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_136","first-page":"53","article-title":"Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo","volume":"1791","author":"Bisogno","year":"2009","journal-title":"Biochim. Et Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1021\/tx1002194","article-title":"Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes\/macrophages by activated organophosphorus insecticides: Role of carboxylesterases 1 and 2","volume":"23","author":"Xie","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.apsb.2019.10.006","article-title":"Monoacylglycerol lipase inhibitors: Modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders","volume":"10","author":"Deng","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1016\/j.bmc.2014.09.012","article-title":"Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL)","volume":"22","author":"Korhonen","year":"2014","journal-title":"Bioorganic Med. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chembiol.2013.01.012","article-title":"Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase","volume":"20","author":"Aaltonen","year":"2013","journal-title":"Chem. Biol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.chembiol.2012.03.009","article-title":"Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates","volume":"19","author":"Chang","year":"2012","journal-title":"Chem. Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.bmcl.2015.02.037","article-title":"Loratadine analogues as MAGL inhibitors","volume":"25","author":"Patel","year":"2015","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s13311-011-0100-y","article-title":"Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase\u2013dual targets of the endocannabinoid system to protect against seizure pathology","volume":"9","author":"Naidoo","year":"2012","journal-title":"Neurotherapeutics"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.chembiol.2008.06.008","article-title":"Covalent inhibitors of human monoacylglycerol lipase: Ligand-assisted characterization of the catalytic site by mass spectrometry and mutational analysis","volume":"15","author":"Zvonok","year":"2008","journal-title":"Chem. Biol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/s41401-022-00912-8","article-title":"A novel monoacylglycerol lipase-targeted 18F-labeled probe for positron emission tomography imaging of brown adipose tissue in the energy network","volume":"43","author":"Cheng","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2018.07.036","article-title":"Monoacylglycerol lipase (MAGL) as a promising therapeutic target","volume":"157","year":"2018","journal-title":"Biochem. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/7\/4050\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:23:44Z","timestamp":1760106224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/7\/4050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":147,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["ijms25074050"],"URL":"https:\/\/doi.org\/10.3390\/ijms25074050","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]}}}